PGEN
PGEN
NASDAQ · Biotechnology

Precigen Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks
$5.32
-0.04 (-0.75%)
PGEN News1 articles
Precigen Surges on Papzimeos Revenue, Narrows Loss in Q1
Precigen (PGEN) shares surged 14% as Q1 revenue of $23.3M beat estimates, fueled by $21.6M from Papzimeos. Net loss narrowed to $7.9M from $54.2M a year ago.
Earnings